158 related articles for article (PubMed ID: 35970584)
1. Lifestyle Interventions for the Prevention of Parkinson Disease: A Recipe for Action.
Janssen Daalen JM; Schootemeijer S; Richard E; Darweesh SKL; Bloem BR
Neurology; 2022 Aug; 99(7 Suppl 1):42-51. PubMed ID: 35970584
[TBL] [Abstract][Full Text] [Related]
2. Statistical Considerations in the Design of Clinical Trials Targeting Prodromal Parkinson Disease.
Macklin EA; Coffey CS; Brumm MC; Seibyl JP
Neurology; 2022 Aug; 99(7 Suppl 1):68-75. PubMed ID: 35970588
[TBL] [Abstract][Full Text] [Related]
3. Advances in markers of prodromal Parkinson disease.
Postuma RB; Berg D
Nat Rev Neurol; 2016 Oct; 12(11):622-634. PubMed ID: 27786242
[TBL] [Abstract][Full Text] [Related]
4. Design of the Park-in-Shape study: a phase II double blind randomized controlled trial evaluating the effects of exercise on motor and non-motor symptoms in Parkinson's disease.
van der Kolk NM; Overeem S; de Vries NM; Kessels RP; Donders R; Brouwer M; Berg D; Post B; Bloem BR
BMC Neurol; 2015 Apr; 15():56. PubMed ID: 25880966
[TBL] [Abstract][Full Text] [Related]
5. The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.
Spencer L; Rollo M; Hauck Y; MacDonald-Wicks L; Wood L; Hutchesson M; Giglia R; Smith R; Collins C
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):88-98. PubMed ID: 26447010
[TBL] [Abstract][Full Text] [Related]
6. Who to Enroll in Parkinson Disease Prevention Trials? The Case for Composite Prodromal Cohorts.
Molsberry SA; Hughes KC; Schwarzschild MA; Ascherio A
Neurology; 2022 Aug; 99(7 Suppl 1):26-33. PubMed ID: 35970591
[TBL] [Abstract][Full Text] [Related]
7. Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson Disease.
Heinzel S; Aho VTE; Suenkel U; von Thaler AK; Schulte C; Deuschle C; Paulin L; Hantunen S; Brockmann K; Eschweiler GW; Maetzler W; Berg D; Auvinen P; Scheperjans F
Ann Neurol; 2020 Aug; 88(2):320-331. PubMed ID: 32441370
[TBL] [Abstract][Full Text] [Related]
8. Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease.
Meles SK; Oertel WH; Leenders KL
Mol Med; 2021 Sep; 27(1):111. PubMed ID: 34530732
[TBL] [Abstract][Full Text] [Related]
9. Cognitive changes in prodromal Parkinson's disease: A review.
Fengler S; Liepelt-Scarfone I; Brockmann K; Schäffer E; Berg D; Kalbe E
Mov Disord; 2017 Dec; 32(12):1655-1666. PubMed ID: 28980730
[TBL] [Abstract][Full Text] [Related]
10. Prodromal local sleep disorders in a rat model of Parkinson's disease cholinopathy, hemiparkinsonism and hemiparkinsonism with cholinopathy.
Petrovic J; Radovanovic L; Saponjic J
Behav Brain Res; 2021 Jan; 397():112957. PubMed ID: 33038348
[TBL] [Abstract][Full Text] [Related]
11. Non-motor extranigral signs and symptoms in Parkinson's disease.
Wolters ECh
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S6-12. PubMed ID: 20083010
[TBL] [Abstract][Full Text] [Related]
12. Evolution of prodromal Parkinson's disease and dementia with Lewy bodies: a prospective study.
Fereshtehnejad SM; Yao C; Pelletier A; Montplaisir JY; Gagnon JF; Postuma RB
Brain; 2019 Jul; 142(7):2051-2067. PubMed ID: 31111143
[TBL] [Abstract][Full Text] [Related]
13. Mediterranean diet adherence is related to reduced probability of prodromal Parkinson's disease.
Maraki MI; Yannakoulia M; Stamelou M; Stefanis L; Xiromerisiou G; Kosmidis MH; Dardiotis E; Hadjigeorgiou GM; Sakka P; Anastasiou CA; Simopoulou E; Scarmeas N
Mov Disord; 2019 Jan; 34(1):48-57. PubMed ID: 30306634
[TBL] [Abstract][Full Text] [Related]
14. The remote assessment of parkinsonism supporting the ongoing development of interventions in Gaucher disease.
Higgins AL; Toffoli M; Mullin S; Lee CY; Koletsi S; Avenali M; Blandini F; Schapira AH
Neurodegener Dis Manag; 2021 Dec; 11(6):451-458. PubMed ID: 34666501
[TBL] [Abstract][Full Text] [Related]
15. Toward Personalized Medicine Approaches for Parkinson Disease Using Digital Technologies.
Khanna A; Jones G
JMIR Form Res; 2023 Sep; 7():e47486. PubMed ID: 37756050
[TBL] [Abstract][Full Text] [Related]
16. The effects of physical exercise on nonmotor symptoms and on neuroimmune RAGE network in experimental parkinsonism.
Viana SD; Pita IR; Lemos C; Rial D; Couceiro P; Rodrigues-Santos P; Caramelo F; Carvalho F; Ali SF; Prediger RD; Fontes Ribeiro CA; Pereira FC
J Appl Physiol (1985); 2017 Jul; 123(1):161-171. PubMed ID: 28385921
[TBL] [Abstract][Full Text] [Related]
17. The prodromal phase of leucine-rich repeat kinase 2-associated Parkinson disease: Clinical and imaging Studies.
Pont-Sunyer C; Tolosa E; Caspell-Garcia C; Coffey C; Alcalay RN; Chan P; Duda JE; Facheris M; Fernández-Santiago R; Marek K; Lomeña F; Marras C; Mondragon E; Saunders-Pullman R; Waro B;
Mov Disord; 2017 May; 32(5):726-738. PubMed ID: 28370517
[TBL] [Abstract][Full Text] [Related]
18. The Concept of Prodromal Parkinson's Disease.
Mahlknecht P; Seppi K; Poewe W
J Parkinsons Dis; 2015; 5(4):681-97. PubMed ID: 26485429
[TBL] [Abstract][Full Text] [Related]
19. Prodromal Parkinson's disease: hype or hope for disease-modification trials?
Mahlknecht P; Marini K; Werkmann M; Poewe W; Seppi K
Transl Neurodegener; 2022 Feb; 11(1):11. PubMed ID: 35184752
[TBL] [Abstract][Full Text] [Related]
20. MDS research criteria for prodromal Parkinson's disease.
Berg D; Postuma RB; Adler CH; Bloem BR; Chan P; Dubois B; Gasser T; Goetz CG; Halliday G; Joseph L; Lang AE; Liepelt-Scarfone I; Litvan I; Marek K; Obeso J; Oertel W; Olanow CW; Poewe W; Stern M; Deuschl G
Mov Disord; 2015 Oct; 30(12):1600-11. PubMed ID: 26474317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
